 TORONTO, ON ACCESSWIRE July 11, 2022 Edesa Biotech, Inc. Nasdaq:EDSA, a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, announced today that Par Nijhawan, MD, Chief Executive Officer, will present at the 2nd Annual ARDS Drug Development Summit being held July 13-15, 2022 in Boston, Mass. Dr. Nijhawans presentation is scheduled for 8:25 am ET on July 14, 2022. 